Suppr超能文献

根据慢性肝病病因分析肝细胞癌患者的死亡原因

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology.

作者信息

Yen Yi-Hao, Kee Kwong-Ming, Li Wei-Feng, Liu Yueh-Wei, Wang Chih-Chi, Hu Tsung-Hui, Tsai Ming-Chao, Kuo Yuan-Hung, Lin Chih-Yun

机构信息

Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.

Liver Transplantation Center, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.

出版信息

Cancers (Basel). 2023 Mar 9;15(6):1687. doi: 10.3390/cancers15061687.

Abstract

This study was conducted to determine whether the causes of death among patients with hepatocellular carcinoma (HCC) differ according to chronic liver disease (CLD) etiology. Between 2011 and 2020, 3977 patients who were newly diagnosed with HCC at our institution were enrolled in this study. We determined whether the cause of death was HCC-related and non-HCC-related. For patients with multiple CLD etiologies, etiology was classified using the following hierarchy: hepatitis C virus (HCV) > hepatitis B virus (HBV) > alcohol-related causes > all negative. All negative was defined as negative for HCV, HBV, and alcohol-related causes. Among 3977 patients, 1415 patients were classified as HCV-related, 1691 patients were HBV-related, 145 patients were alcohol-related, and 725 patients were all negative. HCC-related mortality was the leading cause of death, irrespective of etiology. Among patients who underwent curative treatment, HCC-related mortality was the leading cause of death for patients in the HCV, HBV, and all-negative groups, but not for patients in the alcohol-related group. Among patients 75 years and older who underwent curative treatment, HCC-related mortality was the leading cause of death in the HCV but not HBV or all-negative groups. In conclusion, although most patients with HCC die due to HCC-related causes, non-HCC-related mortality represents a competing event in certain patient subgroups. The current study results underscore the importance of assessing and managing underlying comorbidities, particularly among patients with HCC at risk of non-HCC-related mortality.

摘要

本研究旨在确定肝细胞癌(HCC)患者的死亡原因是否因慢性肝病(CLD)病因不同而有所差异。2011年至2020年期间,本机构新诊断为HCC的3977例患者纳入本研究。我们确定死亡原因是否与HCC相关以及是否与非HCC相关。对于有多种CLD病因的患者,病因分类采用以下层次结构:丙型肝炎病毒(HCV)>乙型肝炎病毒(HBV)>酒精相关病因>所有阴性。所有阴性定义为HCV、HBV及酒精相关病因均为阴性。在3977例患者中,1415例患者被归类为HCV相关,1691例患者为HBV相关,145例患者为酒精相关,725例患者为所有阴性。无论病因如何,HCC相关死亡率都是主要死因。在接受根治性治疗的患者中,HCC相关死亡率是HCV、HBV和所有阴性组患者的主要死因,但不是酒精相关组患者的主要死因。在接受根治性治疗的75岁及以上患者中,HCC相关死亡率是HCV组的主要死因,但不是HBV组或所有阴性组的主要死因。总之,虽然大多数HCC患者死于HCC相关原因,但非HCC相关死亡率在某些患者亚组中是一个竞争事件。当前研究结果强调了评估和管理潜在合并症的重要性,特别是在有非HCC相关死亡风险的HCC患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab10/10046416/9174d5b61bdd/cancers-15-01687-g001a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验